Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephane Steurbaut

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Patient Preference and Adherence|November 11, 2024
Intake Patterns and Experiences of Patients Using Direct Oral Anticoagulants Measured by Electronic Monitoring in Community PharmaciesSara Desmaele, Andreas Capiau, Maxim Grymonprez, et al.
Frontiers in Pharmacology|October 5, 2020
Effectiveness and Safety of Oral Anticoagulants in Older Patients With Atrial Fibrillation: A Systematic Review and Meta-AnalysisMaxim Grymonprez, Stephane Steurbaut, Tine L De Backer, et al.
Cardiovascular Drugs and Therapy|October 12, 2021
Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Versus Warfarin in Patients with Atrial Fibrillation Using P-gp and/or CYP450-Interacting Drugs: a Systematic Review and Meta-analysisMaxim Grymonprez, Kevin Vanspranghe, Stephane Steurbaut, et al.
British Journal of Clinical Pharmacology|February 8, 2022
Impact of P-glycoprotein and/or CYP3A4-interacting drugs on effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: A meta-analysisMaxim Grymonprez, Kevin Vanspranghe, Andreas Capiau, et al.
Thrombosis and Haemostasis|June 27, 2023
The Impact of Polypharmacy on the Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Atrial FibrillationMaxim Grymonprez, Mirko Petrovic, Tine L De Backer, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 22, 2021
Worldwide trends in oral anticoagulant use in patients with atrial fibrillation from 2010 to 2018: a systematic review and meta-analysisMaxim Grymonprez, Cynthia Simoens, Stephane Steurbaut, et al.
International Journal of Medical Informatics|June 9, 2015
Pilot evaluation of an optimized context-specific drug-drug interaction alerting system: A controlled pre-post studyPieter Cornu, Stephane Steurbaut, Kristof Gentens, et al.
Clinical Cardiology|March 26, 2021
The impact of underweight and obesity on outcomes in anticoagulated patients with atrial fibrillation: A systematic review and meta-analysis on the obesity paradoxMaxim Grymonprez, Andreas Capiau, Tine L De Backer, et al.
Frontiers in Pharmacology|October 20, 2023
Key elements in the quality assessment of a type 3 medication reviewAnneleen Robberechts, Melissa Michielsen, Stephane Steurbaut, et al.
Journal of Medical Internet Research|September 9, 2018
Clinical Decision Support Systems for Drug Allergy Checking: Systematic ReviewLaura Légat, Sven Van Laere, Marc Nyssen, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Patient Preference and Adherence|November 11, 2024
Intake Patterns and Experiences of Patients Using Direct Oral Anticoagulants Measured by Electronic Monitoring in Community PharmaciesSara Desmaele, Andreas Capiau, Maxim Grymonprez, et al.
Frontiers in Pharmacology|October 5, 2020
Effectiveness and Safety of Oral Anticoagulants in Older Patients With Atrial Fibrillation: A Systematic Review and Meta-AnalysisMaxim Grymonprez, Stephane Steurbaut, Tine L De Backer, et al.
Cardiovascular Drugs and Therapy|October 12, 2021
Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Versus Warfarin in Patients with Atrial Fibrillation Using P-gp and/or CYP450-Interacting Drugs: a Systematic Review and Meta-analysisMaxim Grymonprez, Kevin Vanspranghe, Stephane Steurbaut, et al.
British Journal of Clinical Pharmacology|February 8, 2022
Impact of P-glycoprotein and/or CYP3A4-interacting drugs on effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: A meta-analysisMaxim Grymonprez, Kevin Vanspranghe, Andreas Capiau, et al.
Thrombosis and Haemostasis|June 27, 2023
The Impact of Polypharmacy on the Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Atrial FibrillationMaxim Grymonprez, Mirko Petrovic, Tine L De Backer, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 22, 2021
Worldwide trends in oral anticoagulant use in patients with atrial fibrillation from 2010 to 2018: a systematic review and meta-analysisMaxim Grymonprez, Cynthia Simoens, Stephane Steurbaut, et al.
International Journal of Medical Informatics|June 9, 2015
Pilot evaluation of an optimized context-specific drug-drug interaction alerting system: A controlled pre-post studyPieter Cornu, Stephane Steurbaut, Kristof Gentens, et al.
Clinical Cardiology|March 26, 2021
The impact of underweight and obesity on outcomes in anticoagulated patients with atrial fibrillation: A systematic review and meta-analysis on the obesity paradoxMaxim Grymonprez, Andreas Capiau, Tine L De Backer, et al.
Frontiers in Pharmacology|October 20, 2023
Key elements in the quality assessment of a type 3 medication reviewAnneleen Robberechts, Melissa Michielsen, Stephane Steurbaut, et al.
Journal of Medical Internet Research|September 9, 2018
Clinical Decision Support Systems for Drug Allergy Checking: Systematic ReviewLaura Légat, Sven Van Laere, Marc Nyssen, et al.
Pageof 7